Goversen B, van der Heyden MAG, van Veen TAB, de Boer TP (2018) The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on I K1
Our peptides are not designed for human consumption or clinical application
B12 injections are elective wellness services and are not intended to diagnose, treat, cure, or prevent disease
Research focus How Reconstitution BAC is studied Summary of contexts in which this compound appears in the preclinical literature
The peptides status as a research-only compound means that these experiments are confined to preclinical models and are interpreted as exploratory rather than definitive evidence for any health claim
Active Constituents: CopHos B Injection : Ethanolamine Phosphate 100 mg/ml, Cyanocobalamin (Vitamin B12) 50 ug/ml Cophos B Injection 100ml